Indeed, a gene expression profiling study of three distinct entities of ALCL, systemic ALK+, systemic ALK− and cutaneous ALK− could not assign the disease to CD4+, CD8+ or CD30+ T-cell origin [73]. The gene discussed is CD4; the disease is anaplastic large cell lymphoma.